Why do women with melanoma do better than men?
Author:
Affiliation:
1. Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, United States
2. Department of Cutaneous Oncology, The Moffitt Cancer Center & Research Institute, Tampa, United States
Abstract
Publisher
eLife Sciences Publications, Ltd
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience
Link
https://cdn.elifesciences.org/articles/33511/elife-33511-v1.pdf
Reference9 articles.
1. MYC on the path to cancer;Dang;Cell,2012
2. Adhesion, migration and communication in melanocytes and melanoma;Haass;Pigment Cell Research,2005
3. Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials;Joosse;Journal of Clinical Oncology,2013
4. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;New England Journal of Medicine,2015
5. The association of BMI and outcomes in metastatic melanoma: a retrospective, multicohort analysis of patients treated with targeted therapy, immunotherapy, or chemotherapy;McQuade;The Lancet. Oncology,2018
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. G protein-coupled estrogen receptor 1 and collagen XVII endodomain expression in human cutaneous melanomas: can they serve as prognostic factors?;Pathology and Oncology Research;2024-08-26
2. The Effect of Body Mass Index on Melanoma Biology, Immunotherapy Efficacy, and Clinical Outcomes: A Narrative Review;International Journal of Molecular Sciences;2024-06-11
3. A Narrative Review of the Role of Estrogen (Receptors) in Melanoma;International Journal of Molecular Sciences;2024-06-06
4. The G protein-coupled oestrogen receptor GPER in health and disease: an update;Nature Reviews Endocrinology;2023-05-16
5. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy;Nature;2022-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3